Paper Details

  1. Home
  2. Paper Details

[Tolerance of famotidine. Study of network of sentinel physicians in pharmaco-vigilance].

Author: ChichmanianR M, HofligerP, Jean-GirardC, MignotG, SpreuxA

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study monitored 200 patients treated with famotidine, a histamine H2 receptor antagonist, for 6 to 8 weeks. The drug was generally well tolerated, with only 2.5% of patients requiring treatment discontinuation due to side effects, primarily neurological.
Paper Details　
Original Abstract of the Article :
This paper presents the results of an intensive surveillance based on a network of general practitioners and following 200 patients treated by famotidine 40 mg per day during 6 to 8 weeks. Four patients with a previous experience of adverse reaction to another H2 antagonist did not relapse with famo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1295124

データ提供：米国国立医学図書館（NLM）

Famotidine: A Well-Tolerated H2 Antagonist

The field of pharmaco-vigilance is essential for ensuring the safety and efficacy of medications. This research examines the tolerance of famotidine, an H2 antagonist, based on data from a network of sentinel physicians. The authors conduct an intensive surveillance study, following 200 patients treated with famotidine for 6 to 8 weeks. This study provides valuable insights into the safety profile of famotidine, addressing potential interactions and adverse effects. This research serves as a testament to the importance of ongoing surveillance in monitoring medication safety.

Famotidine: A Promising Option for H2 Antagonist Therapy

The research demonstrates that famotidine is well-tolerated by patients, with a favorable safety profile. The study reveals that famotidine exhibits few interactions with other commonly used medications and that adverse effects are relatively infrequent. These findings suggest that famotidine is a safe and effective H2 antagonist option for patients requiring this type of therapy.

Navigating the Landscape of Medication Safety

This research emphasizes the importance of continuous pharmaco-vigilance in ensuring medication safety. By carefully monitoring medication use and reporting any adverse effects, healthcare professionals can identify potential risks and ensure that patients receive safe and effective treatment. This research underscores the value of collaborative efforts in pharmaco-vigilance, involving healthcare professionals, researchers, and patients in a concerted effort to improve medication safety and patient outcomes.

Dr.Camel's Conclusion

This research provides a reassuring look at the safety and efficacy of famotidine. It's like finding a reliable oasis in the vast desert of medication choices. By understanding the safety profile of famotidine, healthcare professionals can confidently prescribe this medication, knowing that it is a well-tolerated and effective option for patients in need.

Date :
  1. Date Completed 1993-04-12
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1295124

DOI: Digital Object Identifier

1295124

Related Literature

Article Analysis
・Side Effects of famotidine
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.